Jobs

See allHide authors and affiliations

Science  16 May 2003:
Vol. 300, Issue 5622, pp. 1085
DOI: 10.1126/science.300.5622.1085c

New Hope. After a 3-year stint with the pharmaceutical industry, cancer researcher Michael Friedman is returning to his roots in medicine. Friedman, 59, has been named CEO and president of the City of Hope medical research center near Los Angeles.

A 30-year veteran of the U.S. Public Health Service and former administrator at the National Cancer Institute, he was also acting director of the Food and Drug Administration (FDA) in the late 1990s and approved the direct marketing of drugs to consumers, the re-introduction of thalidomide for select therapies, and a continuing partnership with industry to help fund FDA.

The City of Hope job “weaves together all the threads of my career,” says Friedman, adding that he aims to build on the center's “great strengths in basic biology and clinical research,” particularly work on stem cells and developmental biology.

Clay head. Boston's Clay Mathematics Institute has chosen James Carlson of the University of Utah in Salt Lake City to succeed founding president Arthur Jaffe, a Harvard mathematician who resigned last fall after a simmering feud with the institute's founders.

“It's a way to give something back to the community,” says the 56-year-old Carlson, who has accepted a 3-year term but will continue to run a summer program for high school students at Utah, where he's been a math professor since 1975. “Clay does wonderful things in support of young mathematicians and promising students.”

Carlson says he will lean heavily on a five-person scientific advisory board, rebuilt after two of three former members left in solidarity with Jaffe's departure. “We wanted someone who is congenial and gets along well with everybody,” says Princeton's Andrew Wiles, a member of the advisory board and head of the search committee.

“I wish him luck,” says Jaffe, who clashed with the all-in-the-family board of directors that runs the 5-year-old institute best known for its million-dollar Millennium Prizes (Science, 26 May 2000, p. 1328).

Navigate This Article